Commonwealth of Pennsylvania Public School Empls Retrmt SYS Decreases Position in Elevance Health, Inc. $ELV

Commonwealth of Pennsylvania Public School Empls Retrmt SYS trimmed its position in shares of Elevance Health, Inc. (NYSE:ELV) by 4.4% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 51,694 shares of the company’s stock after selling 2,379 shares during the quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS’s holdings in Elevance Health were worth $18,121,000 at the end of the most recent reporting period.

A number of other institutional investors also recently bought and sold shares of the company. Murphy Middleton Hinkle & Parker Inc. purchased a new stake in shares of Elevance Health in the fourth quarter valued at $5,941,000. Blume Capital Management Inc. lifted its position in shares of Elevance Health by 236.7% in the third quarter. Blume Capital Management Inc. now owns 6,145 shares of the company’s stock valued at $1,986,000 after acquiring an additional 4,320 shares in the last quarter. Victory Capital Management Inc. lifted its position in shares of Elevance Health by 31.1% in the third quarter. Victory Capital Management Inc. now owns 461,693 shares of the company’s stock valued at $149,182,000 after acquiring an additional 109,462 shares in the last quarter. Caprock Group LLC purchased a new stake in shares of Elevance Health in the third quarter valued at $1,638,000. Finally, Bright Rock Capital Management LLC purchased a new stake in shares of Elevance Health in the fourth quarter valued at $7,362,000. 89.24% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several analysts have recently issued reports on the company. Robert W. Baird upped their price objective on Elevance Health from $317.00 to $331.00 and gave the company a “neutral” rating in a research report on Thursday, April 23rd. Evercore reiterated a “hold” rating on shares of Elevance Health in a research note on Tuesday, May 19th. Jefferies Financial Group dropped their target price on Elevance Health from $395.00 to $391.00 and set a “buy” rating for the company in a research note on Monday, April 20th. JPMorgan Chase & Co. upped their target price on Elevance Health from $397.00 to $411.00 and gave the company an “overweight” rating in a research note on Tuesday, April 28th. Finally, Barclays upped their target price on Elevance Health from $408.00 to $480.00 and gave the company an “overweight” rating in a research note on Tuesday, May 26th. Fourteen research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the stock. According to data from MarketBeat, Elevance Health has an average rating of “Moderate Buy” and a consensus price target of $403.11.

Elevance Health Stock Performance

Elevance Health stock opened at $394.40 on Monday. The stock’s 50-day moving average is $343.75 and its 200-day moving average is $339.15. The company has a market cap of $85.65 billion, a price-to-earnings ratio of 16.78, a price-to-earnings-growth ratio of 2.22 and a beta of 0.67. The company has a debt-to-equity ratio of 0.70, a current ratio of 1.48 and a quick ratio of 1.48. Elevance Health, Inc. has a 12 month low of $273.71 and a 12 month high of $408.00.

Elevance Health (NYSE:ELV) last released its quarterly earnings data on Wednesday, April 22nd. The company reported $12.58 EPS for the quarter, topping analysts’ consensus estimates of $10.74 by $1.84. The company had revenue of $49.49 billion for the quarter, compared to the consensus estimate of $48.21 billion. Elevance Health had a return on equity of 15.58% and a net margin of 2.62%.The company’s quarterly revenue was up 1.5% compared to the same quarter last year. During the same period last year, the business posted $11.97 EPS. Elevance Health has set its FY 2026 guidance at 19.850- EPS. Equities analysts anticipate that Elevance Health, Inc. will post 26.94 earnings per share for the current year.

Elevance Health Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, June 25th. Stockholders of record on Wednesday, June 10th will be issued a $1.72 dividend. This represents a $6.88 dividend on an annualized basis and a dividend yield of 1.7%. The ex-dividend date is Wednesday, June 10th. Elevance Health’s dividend payout ratio (DPR) is 29.26%.

Elevance Health Profile

Elevance Health, Inc (NYSE: ELV) is a large U.S.-based health benefits company that provides a broad range of health insurance products and related services. Headquartered in Indianapolis, the company rebranded from Anthem, Inc to Elevance Health in 2022 while continuing to operate consumer-facing health plans under established state and national brands. Gail Boudreaux serves as chief executive officer and president, leading the company’s strategic focus on integrated health care and benefit delivery.

Elevance’s core activities include offering medical and specialty health plans for individuals, employers and government programs, including Medicare and Medicaid managed-care products.